GameChangers

GameChangers

By Today.it , Cecilia SonginiBusinessEntrepreneurshipNewsNews CommentaryBusiness News
Download on the App Store

GameChangers episodes

  • 3 – Come nasce un imprenditore: la storia di Luca, fondatore di Learnn

    La terza puntata di Gamechangers - Il Podcast, vede protagonista Luca Mastella, giovane imprenditore e fondatore di Learnn, la piattaforma che ha rivoluzionato il mondo dell’educazione digitale. La sua storia inizia sul parquet, con il sogno di diventare un campione del basket: ma quando un infortunio pone fine alla carriera sportiva, Luca si trova di fronte a un bivio che lo porta a cambiare completamente rotta. Il suo percorso dimostra che la capacità di adattarsi, imparare e reinventarsi non solo può cambiare una vita, ma può anche ispirare un’intera generazione.

    Per rimanere aggiornati sulle prossime puntate del Podcast e tante altre news interessanti, seguici sui nostri canali Social: Facebook, Instagram, TikTok.

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    48 min
  • 2 - Tommy Verse ci parla di startup, economia ed educazione finanziaria

    “Money, money, money, must be funny in the rich man's world" cantavano gli ABBA negli anni '70. Ma come la mettiamo con il mondo di tutti gli altri? In questa puntata di Gamechangers - Il Podcast, Cecilia Songini intervista Tommy.Verse, content creator che ha fatto della divulgazione economico-finanziaria la sua missione, soprattutto in un Paese come l’Italia, dove c’è ancora molto da imparare. Nessuna “ricetta magica” o formule per arricchirsi in un lampo, ma tante storie interessanti e prospettive nuove per capire come tutto ciò che riguarda i soldi (e chi li muove) possa impattare la quotidianità.

    Per rimanere aggiornati sulle prossime puntate del Podcast e tante altre news interessanti, seguici sui nostri canali Social: Facebook, Instagram, TikTok.

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    40 min
  • 1 – Arte Drag, identità sessuale, diritti LGBTQIA+ con Lina Galore

    Essere una Drag Queen significa molto di più che indossare parrucche e costumi scintillanti. In questa puntata, Lina Galore (alias Giovanni Montuori), vincitrice di Drag Race Italia 3, ci accompagna in un viaggio irriverente tra spettacolo e attivismo, dove si parla di autodeterminazione, orgoglio LGBTQIA+ e dell’importanza di sfidare i limiti imposti dalla società. Tra glitter e impegno sociale, scopriremo come essere drag significhi riscrivere le regole dell’espressione personale per costruire un futuro più inclusivo per tutti.

    Per rimanere aggiornati sulle prossime puntate del Podcast e tante altre news interessanti, seguici sui nostri canali Social: Facebook, Instagram, TikTok.

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    46 min
  • GameChangers Birthday | GameChangers
    It's the GameChangers' Birthday! This episode is a rapid review of a few subjects to celebrate the first year of GameChangers. From oral iron administration to the use of metronidazole with alcohol or serotonin syndrome, this episode has all the ingredients for a celebration!
    GameChangers' host, Geoff Wall, just released new music! Check out his latest EP here: https://open.spotify.com/artist/0J26ngHZz2cf6mQR3UiEHW?827= or wherever you listen to music!
    Reference: Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017 Nov;4(11):e524-e533. doi: 10.1016/S2352-3026(17)30182-5. Epub 2017 Oct 9. PMID: 29032957.
    Kaundal R, Bhatia P, Jain A, et al. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol. 2020 Jan;99(1):57-63. doi: 10.1007/s00277-019-03871-z. Epub 2019 Dec 6. PMID: 31811360.
    Visapää JP, Tillonen JS, Kaihovaara PS, et al. Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother. 2002 Jun;36(6):971-4. doi: 10.1345/aph.1A066. PMID: 12022894.
    Orlova Y, Rizzoli P, Loder E. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA Neurol. 2018 May 1;75(5):566-572. doi: 10.1001/jamaneurol.2017.5144. PMID: 29482205; PMCID: PMC5885255.
    CPE details for GameChangers Podcast April 2021
    Learning Objective: Discuss the evidence-based dosing of oral iron supplementation.
    0107-0000-21-158-H01-P
    0.2 CEU/2 Hrs (Knowledge)
    Initial Release Date: 04/06/21
    Expiration Date: 03/02/24
    Additional CPE information is located at https://www.ceimpact.com/podcast 
    See omnystudio.com/listener for privacy information.
    Learn more about your ad choices. Visit megaphone.fm/adchoices
    24 min
  • You Never Give Me Your Money | GameChangers
    Alzheimer's Disease and Related Dementias are a terrible disease on individuals, caregivers, and communities. There are no cures. However, new data has come out discussing the risk factors, polypharmacy, and a potential early detection opportunity. It's time to de-prescribe and follow the money.
    Reference: Nicholas LH, Langa KM, Bynum JPW, Hsu JW. Financial Presentation of Alzheimer Disease and Related Dementias. JAMA Intern Med. 2021;181(2):220–227. doi:10.1001/jamainternmed.2020.6432
    Maust DT, Strominger J, Kim HM, et al. Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US. JAMA. 2021;325(10):952–961. doi:10.1001/jama.2021.1195
    CPE details for GameChangers Podcast April 2021
    Learning Objective: Discuss if adverse financial outcomes may be a risk factor for future dementia diagnosis.
    0107-0000-21-158-H01-P
    0.2 CEU/2 Hrs (Knowledge)
    Initial Release Date: 04/06/21
    Expiration Date: 03/02/24
    Additional CPE information is located at https://www.ceimpact.com/podcast 
    Disclosure: Dr. Galdo is a member of the Board of Directors for the Alabama Chapter of the Alzheimer's Association.
    See omnystudio.com/listener for privacy information.
    Learn more about your ad choices. Visit megaphone.fm/adchoices
    37 min
  • The Good the Bad & the Ugly | GameChangers
    More and more vaccines are getting authorization in the United States to prevent COVID-19. However, sometimes a vaccine trial is not always effective. But even failure can provide new insights. Learn about the Janssen COVID-19 vaccine and what happened with the recent Hepatitis C vaccine candidate.
    This podcast was recorded prior to the joint CDC and FDA statement on the Johnson & Johnson/Janssen COVID-19 vaccine on April 13th. On April 13th, 2021, the CDC and FDA issued a joint statement recommending a pause on the use of the Johnson & Johnson/Janssen COVID-19 vaccine until further notice. Click here for the full statement.
    Reference: Page K, Melia M, Veenhuis R, et al. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. N Engl J Med 2021; 384:541-549. DOI: 10.1056/NEJMoa2023345
    Fact Sheet for Healthcare Providers Administering Vaccine Emergency Use Authorization of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019. https://www.fda.gov/media/146304/download 
    CPE details for GameChangers Podcast April 2021
    Learning Objective: Describe the outcomes of a recently published trial on hepatitis C vaccine candidates.
    0107-0000-21-158-H01-P
    0.2 CEU/2 Hrs (Knowledge)
    Initial Release Date: 04/06/21
    Expiration Date: 03/02/24
    Additional CPE information is located at https://www.ceimpact.com/podcast 
    See omnystudio.com/listener for privacy information.
    Learn more about your ad choices. Visit megaphone.fm/adchoices
    31 min
  • Don't Stop Me Now | GameChangers
    The battle against the COVID-19 pandemic has continued for over a year. The evidence continues to update and change, and more and more people are becoming vaccinated. This episode provides a review of the newest literature including guidance on vaccinated individuals. But, remember, don't stop wearing a mask now!
    Reference: Interim Public Health Recommendations for Fully Vaccinated People. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html.
    CPE details for GameChangers Podcast April 2021
    Learning Objective: Describe evidence-based recommendations to mitigate SARS-CoV-2 infections
    0107-0000-21-158-H01-P
    0.2 CEU/2 Hrs (Knowledge)
    Initial Release Date: 04/06/21
    Expiration Date: 03/02/24
    Additional CPE information is located at https://www.ceimpact.com/podcast 
    See omnystudio.com/listener for privacy information.
    Learn more about your ad choices. Visit megaphone.fm/adchoices
    31 min
  • Aaay, Updates! | GameChangers
    Recently the American Gastroenterological Society updated their guidelines for treatment for a true medical emergency: gastric and esophageal bleeding. This episode reviews the guidelines and highlights the importance of several changes to management. Today's episode is sponsored by a special CEimpact FREE Law focused webinar:
    Make sure to save your spot for FREE LIVE LAW CE April 1st. 7PM. https://ceimpact.com/law 
    Reference: Henry Z, Patel K, Patton H, et al. AGA Clinical Practice Update on Management of Bleeding Gastric Varices: Expert Review. Clinical Gastroenterology and Hepatology. 2021. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S154235652100077X?returnurl=null&referrer=null 
    CPE details for GameChangers Podcast March 2021
    Learning Objective: Identify appropriate therapy for individuals with variceal bleeds based on the new guidelines
    0107-0000-21-097-H01-P
    0.25 CEU/2.5 Hrs (Knowledge)
    Initial Release Date: 03/02/21
    Expiration Date: 03/02/24
    Additional CPE information is located at https://www.ceimpact.com/podcast 
    See omnystudio.com/listener for privacy information.
    Learn more about your ad choices. Visit megaphone.fm/adchoices
    27 min
  • Fungus Amongus | GameChangers
    Aspirgillosis is a deadly fungal infection that is a major cause of mortality in patients with impaired immune systems. The current standard of care has been voriconazole due to the favorable side effect profile compared to amphotericin. However, posaconazole may not have there adverse effects and be a reasonable course of therapy. Is voriconazole just just a phase?
    Today's episode is sponsored by a special CEimpact FREE Law focused webinar: 
    Save your spot - FREE LIVE LAW CE
    webinar on April 1st.  SPOTS ARE LIMITED!
    https://ceimpact.com/law 
    Reference: Maertens JA, Rahav G, Lee DG, et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet. 2021 Feb 6;397(10273):499-509. doi: 10.1016/S0140- 6736(21)00219-1. PMID: 33549194.
    Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, Volume 63, Issue 4, 15 August 2016, Pages e1–e60, hMps://doi.org/10.1093/cid/ciw326
    CPE details for GameChangers Podcast March 2021
    Learning Objective: Develop appropriate treatment of aspergillosis infections based on clinical studies.
    0107-0000-21-097-H01-P
    0.25 CEU/2.5 Hrs (Knowledge)
    Initial Release Date: 03/02/21
    Expiration Date: 03/02/24
    Additional CPE information is located at https://www.ceimpact.com/podcast
    See omnystudio.com/listener for privacy information.
    Learn more about your ad choices. Visit megaphone.fm/adchoices
    28 min
  • Lose Yourself | GameChangers
    The recently published STEP trial showed a dramatic effect on weight loss with the weekly injectable semaglutide versus placebo. Lay media picked up the headlines from this potential "GameChanger" medication for weight loss. With this one shot will patient lose themselves?
    Reference: Wilding J, Batterham R, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. February 10, 2021. DOI: 10.1056/NEJMoa2032183
    CPE details for GameChangers Podcast March 2021
    Learning Objective: Discuss the design of the STEP trial
    0107-0000-21-097-H01-P
    0.25 CEU/2.5 Hrs (Knowledge)
    Initial Release Date: 03/02/21
    Expiration Date: 03/02/24
    Additional CPE information is located at https://www.ceimpact.com/podcast 
    See omnystudio.com/listener for privacy information.
    Learn more about your ad choices. Visit megaphone.fm/adchoices
    26 min

About GameChangers

From the publisher's feed

In un mondo in continua trasformazione, emergono persone capaci di ridefinire le regole del gioco. Sono loro i Gamechangers, protagonisti dell’omonimo podcast di Today.it: ogni episodio, guidato da…